Is there a role for tailoring treatment dose according to severity of symptoms?
Tailoring treatment dose according to severity of manic symptoms
Alterations of the cerebellum and basal ganglia in bipolar disorder mood states detected by quantitative T1ρ mapping
Assessment of cognitive functions in bipolar I disorder: A 1-year naturalistic follow-up study
Systematic genetic analyses of genome-wide association study data reveal an association between the key nucleosome remodeling and deacetylase complex and bipolar disorder development
Three-year follow-up after psychotherapy for young people with bipolar disorder
Right unilateral electroconvulsive therapy does not cause more cognitive impairment than pharmacologic treatment in treatment-resistant bipolar depression: A 6-month randomized controlled trial follow-up study
Risk of recurrence after a single manic or mixed episode – a systematic review and meta-analysis
The clinical course of late-life bipolar disorder, looking back and forward
Patients with chronic bipolar disorder exhibit widespread increases in extracellular free water
Superior anti-suicidal effects of electroconvulsive therapy in unipolar disorder and bipolar depression
Eye gaze perception in bipolar disorder: Self-referential bias but intact perceptual sensitivity
Hastening treatment development in bipolar disorder: Evaluation of consensus-based recommendations for cognition trials
Tinkering at the margins
Altered N170 and mood symptoms in bipolar disorder: An electrophysiological study of configural face processing
Neurocognitive functioning, clinical course and functional outcome in first-treatment bipolar I disorder patients with and without clinical relapse: A 1-year follow-up study
Measurement tools for assessment of older age bipolar disorder: A systematic review of the recent global literature
Disrupted cortico-limbic connectivity during reward processing in remitted bipolar I disorder
Reduced electroencephalogram responses to standard and target auditory stimuli in bipolar disorder and the impact of psychotic features: Analysis of event-related potentials, spectral power, and inter-trial coherence
Are patients with bipolar disorder and comorbid attention-deficit hyperactivity disorder more neurocognitively impaired?
Equivalent linear change in cognition between individuals with bipolar disorder and healthy controls over 5 years
Systemic challenges in bipolar disorder management: A patient-centered approach
Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force
Outcomes for bipolar patients assessed in the French expert center network: A 2-year follow-up observational study (FondaMental Advanced Centers of Expertise for Bipolar Disorder [FACE-BD])
Psychosis in bipolar disorder: Does it represent a more “severe” illness?
Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder
On the centrality of mixed features in mood disorders: Listening to Kraepelin and Weygandt and moving forward
Mixed state and suicide: Is the effect of mixed state on suicidal behavior more than the sum of its parts?
Cortical inhibition in symptomatic and remitted mania compared to healthy subjects: A cross-sectional study
Differential neurometabolite alterations in brains of medication-free individuals with bipolar disorder and those with unipolar depression: a two-dimensional proton magnetic resonance spectroscopy study
Preattentive dysfunction in patients with bipolar disorder as revealed by the pitch-mismatch negativity: a magnetoencephalography (MEG) study
The Bipolar Prodrome Symptom Interview and Scale–Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls
The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study
C9ORF72 repeat expansion and bipolar disorder – is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder
Minor physical anomalies in schizophrenia and bipolar I disorder and the neurodevelopmental continuum of psychosis
Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder